# Chris Mansi

> Chris Mansi is a Cambridge and UCL-trained neurosurgeon turned AI entrepreneur, and the Co-founder and CEO of Viz.ai - the company that puts an AI brain between a CT scanner and a surgeon so that patients who are about to die of a stroke stop dying from delays. Named to TIME100 AI in 2024, Mansi built Viz.ai from a Stanford dorm-room insight into a platform covering nearly 2,000 U.S. hospitals and 230 million lives, reducing stroke diagnostic timelines by more than an hour - one patient at a time, every ten seconds.

- **Role:** Co-founder & CEO at Viz.ai
- **Organizations:** Viz.ai, Stanford University (Biodesign), University College London, University of Cambridge, King's College Hospital London, National Hospital for Neurology & Neurosurgery, Queen Square
- **From:** Newcastle, United Kingdom
- **Nationality:** British
- **Education:** BA Surgery / MA Cognitive Science, University of Cambridge, MBBS (Bachelor of Medicine, Bachelor of Surgery), University College London, MBA, Stanford Biodesign Medical Innovation, Stanford University
- **Known for:** Named to TIME100 AI 2024 list as an Innovator, Built Viz.ai from a Stanford MBA project to a $1.2B company covering 230 million lives, Secured first-ever FDA de Novo clearance for computer-aided triage & notification (Viz LVO, 2018)

## Career timeline

- **pre-2014** — Trained and practiced as a neurosurgeon in the UK at Queen Square (National Hospital for Neurology & Neurosurgery) and King's College Hospital
- **2014** — Founded EDUSURG Ltd., an online medical education platform, while still in surgical residency
- **2014-2016** — Enrolled in Stanford MBA and Stanford Biodesign Medical Innovation Fellowship
- **2016** — Co-founded Viz.ai with David Golan; Eric Schmidt (Google CEO) was an early supporter and funder
- **2018** — Viz LVO algorithm received first-ever FDA de Novo clearance for computer-aided triage and notification; raised $30M Series A
- **2019** — Raised $50M Series B led by Greenoaks with GV, Kleiner Perkins, CRV, Threshold Ventures
- **2021** — Raised $71M Series C led by Scale Venture Partners and Insight Partners
- **2023** — Raised $100M Series D at $1.2B valuation; honored by Goldman Sachs for Entrepreneurship; named AIMed AI in Healthcare Entrepreneur of the Year
- **2024** — Named to TIME100 AI list as an Innovator; Viz.ai named one of Fast Company's 50 Most Innovative Companies
- **2025** — Viz.ai achieves profitability in healthcare business; platform covers nearly 2,000 hospitals and 230M lives; launches Viz Oncology, Viz Assist, and Viz Agent Studio
- **2026** — Announced strategic collaboration with Johnson & Johnson for Subdural Hemorrhage AI detection solution

## Achievements

- Named to TIME100 AI 2024 list as an Innovator
- Built Viz.ai from a Stanford MBA project to a $1.2B company covering 230 million lives
- Secured first-ever FDA de Novo clearance for computer-aided triage & notification (Viz LVO, 2018)
- Grew platform to nearly 2,000 U.S. hospitals and 60,000 healthcare providers
- Reduced stroke diagnostic timelines by 66 minutes in participating hospitals
- Achieved profitability in healthcare business in 2025
- Named one of Fast Company's 50 Most Innovative Companies (2024)
- Honored by Goldman Sachs for Entrepreneurship (2023)
- AIMed AI in Healthcare Entrepreneur of the Year (2023)
- Modern Medicine 40 Under 40 recognition
- Three consecutive Edison Awards for Viz.ai
- 50+ FDA-cleared AI algorithms across the platform

## Latest updates

- **2026-04** — Viz.ai announces strategic collaboration with Johnson & Johnson to expand access to AI-powered Subdural Hemorrhage care
- **2026-01** — Viz.ai closes 2025 with record scale, achieving profitability in healthcare business while accelerating life sciences growth
- **2025-00** — Launched Viz Oncology, Viz Assist, and Viz Agent Studio for custom AI Care Pathways
- **2024-09** — Named to TIME100 AI 2024 list as an Innovator
- **2024-00** — Viz.ai named one of Fast Company's 50 Most Innovative Companies; platform reaches 230M lives covered

## Links

- Website: https://viz.ai
- LinkedIn: http://www.linkedin.com/in/chrismansimd
- Twitter/X: https://twitter.com/viz_ai
- Facebook: https://www.facebook.com/viz.ai.hq

---

Profile page: https://yespress.io/chris-mansi
Published by YesPress — https://yespress.io
Last updated: 2026-05-13